Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis

This study has been terminated.
(the study was terminated because of slow enrollment)
Immunex Corporation
Information provided by:
Amgen Identifier:
First received: March 5, 2004
Last updated: April 30, 2009
Last verified: April 2009
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2004
  Primary Completion Date: May 2004 (Final data collection date for primary outcome measure)